BRPI0415225A - composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos - Google Patents

composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos

Info

Publication number
BRPI0415225A
BRPI0415225A BRPI0415225-5A BRPI0415225A BRPI0415225A BR PI0415225 A BRPI0415225 A BR PI0415225A BR PI0415225 A BRPI0415225 A BR PI0415225A BR PI0415225 A BRPI0415225 A BR PI0415225A
Authority
BR
Brazil
Prior art keywords
topical compositions
dermatitis
telmesteìna
treatment
dermatological disorders
Prior art date
Application number
BRPI0415225-5A
Other languages
English (en)
Inventor
Marco Mastrodonato
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Publication of BRPI0415225A publication Critical patent/BRPI0415225A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

"COMPOSIçõES TóPICAS COMPREENDENDO TELMESTEìNA PARA O TRATAMENTO DE DISTúRBIOS DERMATOLóGICOS". A presente invenção refere-se a composições tópicas, como cremes e loções, que compreendem ou consistem essencialmente em telmesteína ou seu sal farmaceuticamente aceitável, como ingrediente ativo, e a métodos para seu uso no tratamento de uma variedade de doenças e distúrbios dermatológicos, incluindo dermatite atópica (eczema), dermatite de contato alérgica, dermatite seborróica, dermatite de radiação, psoríase, xerose e atopia.
BRPI0415225-5A 2003-10-09 2004-10-07 composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos BRPI0415225A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001941A ITMI20031941A1 (it) 2003-10-09 2003-10-09 Composizioni farmaceutiche topiche per il trattamento delle dermatiti
PCT/EP2004/011228 WO2005037275A1 (en) 2003-10-09 2004-10-07 Topical compositions comprising telmesteine for treating dermatological disorders

Publications (1)

Publication Number Publication Date
BRPI0415225A true BRPI0415225A (pt) 2006-12-05

Family

ID=34452248

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0415225-5A BRPI0415225A (pt) 2003-10-09 2004-10-07 composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos

Country Status (11)

Country Link
US (2) US20070213381A1 (pt)
EP (1) EP1670464B1 (pt)
JP (1) JP2007508264A (pt)
CN (1) CN1863529A (pt)
AT (1) ATE502636T1 (pt)
AU (2) AU2004281521B2 (pt)
BR (1) BRPI0415225A (pt)
CA (1) CA2540859A1 (pt)
DE (1) DE602004031964D1 (pt)
IT (1) ITMI20031941A1 (pt)
WO (1) WO2005037275A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2471135A (en) * 2009-06-19 2010-12-22 H D S Ltd Hair dye composition and use in reducing contact allergy
EP2451796B1 (en) * 2009-07-08 2013-04-17 Dermira (Canada), Inc. Tofa analogs useful in treating dermatological disorders or conditions
US20120109042A1 (en) * 2010-10-28 2012-05-03 John Koo Methods of Treating Diseased Tissue
KR101670765B1 (ko) * 2014-09-19 2016-11-01 주식회사 명진뉴텍 글리신계 물질을 포함하는 방부조성물
DK3421093T3 (da) 2017-06-27 2020-12-07 Daxxin AB Væskeformig sammensætning til vask af hovedbund og hår eller til vask af hud, som omfatter piroctonolamin
CN110831567B (zh) 2017-06-30 2023-01-24 宝洁公司 包含2-吡啶酚-n-氧化物材料和一种铁螯合剂的毛发护理组合物
US10543164B2 (en) 2017-06-30 2020-01-28 The Procter & Gamble Company Deodorant compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE74354T1 (de) * 1988-06-29 1992-04-15 Yason Srl N-karbethoxy-4-thiazolin-karbonsaeure, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
AU7176094A (en) * 1993-06-18 1995-01-17 Arcturus Pharmaceutical Corporation Method for treating hyperkeratosis and diseases mediated by proteases
ITMI20020756A1 (it) * 2002-04-09 2003-10-09 Sinclair Pharma S R L Composizioni farmaceutiche topiche per il trattamento delle dermatiti

Also Published As

Publication number Publication date
AU2008203101A1 (en) 2008-08-07
AU2004281521B2 (en) 2008-04-17
DE602004031964D1 (de) 2011-05-05
EP1670464B1 (en) 2011-03-23
AU2004281521A1 (en) 2005-04-28
CA2540859A1 (en) 2005-04-28
EP1670464A1 (en) 2006-06-21
ITMI20031941A1 (it) 2005-04-10
US20070213381A1 (en) 2007-09-13
US20100130568A1 (en) 2010-05-27
WO2005037275A1 (en) 2005-04-28
US8431601B2 (en) 2013-04-30
ATE502636T1 (de) 2011-04-15
JP2007508264A (ja) 2007-04-05
CN1863529A (zh) 2006-11-15

Similar Documents

Publication Publication Date Title
WO2006120682A3 (en) Compositions and methods for treating hyperproliferative epidermal diseases
BRPI0307550B8 (pt) composição farmacêutica em gel tópica, de adapaleno 0,3%
RU2013141845A (ru) Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа
WO2017182885A3 (en) Compositions for the treatment of hyperkeratosis disorders
WO2007046097A3 (en) Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
BR0212576A (pt) Método para o tratamento de distúrbios da pele
SA519410993B1 (ar) النشاط المضاد للبكتيريا لأوليجو سكاريد من جالاكتو وزيليتول في العلاجات الجلدية
PL1893237T3 (pl) Kompozycja farmaceutyczna zawierająca elastomer poliorganosiloksanowy i solubilizowany składnik aktywny
DE60315704D1 (de) Tetrahydronaphtalen-derivate
GEP20135900B (en) Emollient composition
CA2566776A1 (en) Method for ameliorating an inflammatory skin condition
BRPI0415225A (pt) composições tópicas compreendendo telmesteìna para o tratamento de distúrbios dermatológicos
BR112014031706A2 (pt) composição farmacêutica oral; forma de composição farmacêutica oral; método de redução de efeito de alimento de itraconazol em um indivíduo; método de redução de variabilidade em um mesmo indivíduo de itraconazol; método de redução de variabilidade entre indivíduos de itraconazol; método de tratamento de onicomicose; método de tratamento de uma doença ou afecção e método de tratamento de câncer
WO2018106108A8 (en) Topical pharmaceutical composition containing phenytoin and a (co -)an algesic for the treatment of chronic pain
TW200517137A (en) Method for decreasing sebum production
BR112012030006A2 (pt) composições farmacêuticas tópicas
BRPI0417116A (pt) usos de uma quantidade eficaz de ondansetron e composição para tratamento tópico de uma inflamação
WO2006108414A3 (de) Mittel zur therapie und prophylaxe von hauterkrankungen
WO2012001082A3 (en) Moisturizing composition with spf 30
WO2009036751A3 (de) Kosmetische oder dermatologische zusammensetzung zur topischen verwendung
WO2017205779A3 (en) Compositions and methods for treating disorders related to inflammasome activity and il-1alpha expression
UY26945A1 (es) Alcanosulfonatos de fenoxifenilo
ATE444071T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hauterkrankungen
WO2010000686A2 (en) Composition for topical use

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.